You just read:

Blueprint Medicines Announces Updated NAVIGATOR Trial Results in Patients with Advanced Gastrointestinal Stromal Tumors Supporting Development of Avapritinib Across All Lines of Therapy

News provided by

Blueprint Medicines

Nov 15, 2018, 07:00 ET